Literature DB >> 29348184

Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials.

Stefano Barco1, Eric Vicaut2, Frederikus A Klok1, Mareike Lankeit1, Guy Meyer3,4,5, Stavros V Konstantinides6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29348184     DOI： 10.1183/13993003.01775-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Acute pulmonary embolism.

Authors:  Luke Howard
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

2.  Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial.

Authors:  Olivier Sanchez; Anaïs Charles-Nelson; Walter Ageno; Stefano Barco; Harald Binder; Gilles Chatellier; Daniel Duerschmied; Klaus Empen; Melanie Ferreira; Philippe Girard; Menno V Huisman; David Jiménez; Sandrine Katsahian; Matija Kozak; Mareike Lankeit; Nicolas Meneveau; Piotr Pruszczyk; Antoniu Petris; Marc Righini; Stephan Rosenkranz; Sebastian Schellong; Branislav Stefanovic; Peter Verhamme; Kerstin de Wit; Eric Vicaut; Andreas Zirlik; Stavros V Konstantinides; Guy Meyer
Journal:  Thromb Haemost       Date:  2021-10-31       Impact factor: 6.681

Review 3.  Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives.

Authors:  Antonio Leidi; Stijn Bex; Marc Righini; Amandine Berner; Olivier Grosgurin; Christophe Marti
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

4.  Comparison of two scores in predicting pulmonary embolism-related adverse events in intermediate-high-risk patients: a systematic review and meta-analysis.

Authors:  Carlo Bova; Ernesto Vigna; Massimo Gentile; Francesca Serena Pignataro
Journal:  Intern Emerg Med       Date:  2022-03-23       Impact factor: 5.472

5.  Immediate and late impact of reperfusion therapies in acute pulmonary embolism.

Authors:  Luca Valerio; Frederikus A Klok; Stefano Barco
Journal:  Eur Heart J Suppl       Date:  2019-11-21       Impact factor: 1.803

6.  Future perspectives in catheter-based treatment of pulmonary embolism.

Authors:  Andrew S P Sharp; Antonious Attallah
Journal:  Eur Heart J Suppl       Date:  2019-11-21       Impact factor: 1.803

7.  Short-term prognostic value of clinical data in hospitalized patients with intermediate-risk acute pulmonary embolism.

Authors:  Jichun Liu; Yuanyuan Liu; Feilong Zhang; Cong Fu; Yang Ling; Ping Fang; Xiangrong Xie; Xianghai Wang; Hao Yang; Youquan Wei; Jinfeng Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-07-28       Impact factor: 2.174
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.